GlassScriptPhysician profile
Lacey Rovinelli
NPI 1043685613
$3,832.39
in general payments reported to CMS, 2019-2025
31 companies · $962 in 2025
The $962 reported for 2025 was more than what 89% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $309 · 2022: $586 · 2023: $766 · 2024: $1,209 · 2025: $962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,937.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $912.94 | 2022-2025 | Impella |
| Atricure, INC. | $847.97 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System, Atriclip Laa Exclusion System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $462.74 | 2023-2025 | Lifevest |
| Edwards Lifesciences Corporation | $200.06 | 2021-2025 | Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve, Hemosphere |
| Getinge USA Sales, LLC | $174.21 | 2022-2023 | Vasoview Hemopro 2 |
| Becton, Dickinson and Company | $107.36 | 2025 | Hemosphere |
| Sanofi-Aventis U.S. LLC | $100.00 | 2022 | |
| Ethicon US, LLC | $89.67 | 2021-2023 | Echelon Flex, Prolene, Vistaseal |
| Philips North America LLC | $87.07 | 2023-2024 | (Am5) Lead Management |
| Corcym INC | $86.82 | 2022-2025 | Perceval |
| Kestra Medical Technology Services, INC. | $79.10 | 2024-2025 | Assure Wcd |
| Lsi Solutions INC | $77.92 | 2022-2025 | Cor-Knot, Valvevault, Cor Knot |
| Baxter Healthcare | $69.59 | 2021-2023 | Floseal |
| Kci USA, INC. | $66.68 | 2022-2023 | Prevena |
| Inari Medical, INC. | $64.02 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $43.01 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $38.44 | 2021-2022 | |
| Stryker Corporation | $33.13 | 2024 | Surgicount |
| Depuy Synthes Sales INC. | $31.45 | 2025 | Zipfix |
| Aroa Biosurgery Incorporated | $31.32 | 2022-2025 | |
| Integra Lifesciences Corporation | $30.12 | 2023 | Codman Certas, Duraseal Exact Spinal Sealant System, Cusa Clarity |
| Abbvie INC. | $26.81 | 2021 | |
| Medtronic, INC. | $25.40 | 2023 | Invos |
| Biomerieux INC | $23.58 | 2023 | Nephrocheck Liquid Control Kit |
| Cvrx, INC. | $19.84 | 2024 | Barostim Neo System |
| La Jolla Pharmaceutical Company | $19.43 | 2024 | Giapreza |
| Smith+Nephew, INC. | $18.12 | 2024 | Renasys Touch, Pico 14 |
| Pacira Pharmaceuticals Incorporated | $17.82 | 2021 | |
| Terumo Cardiovascular Systems Corporation | $16.48 | 2021 | |
| Abbott Laboratories | $15.81 | 2023 | Epic |
| Angiodynamics, INC. | $15.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lacey Rovinelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.